Which of these 3 FTSE 100 ‘safe stocks’ would I buy now?

These FTSE 100 shares have seen softening share prices as investor attention turned to cyclicals and Covid-19 impacted their sales.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

2020 was a good year for safe stocks or defensive shares as pessimism hung over investors’ mood. But 2021 has not been quite as benevolent as the bulls came charging back into the stock market. FTSE 100 consumer staples and healthcare stocks have sagged as a result.

But can this be a good time to start buying these stocks? Investors’ interest could return to them as cyclical stocks become pricier by comparison.

I looked at three that have released updates recently. 

#1. Unilever: signs of turnaround

The FTSE 100 consumer goods giant Unilever (LSE: ULVR) is a big gainer at the stock market today as I write, after it posted its trading update. Even though its turnover, based on generally accepted accounting principles (GAAP), is down by around 1% for the first quarter (Q1) of 2021, its underlying numbers are strong. 

Underlying sales growth is up 5.7% to €12.3bn, driven largely by volume growth. It has benefited from a weak base of 2020, which I expect will continue to drive the rest of 2021 as well. It expects growth to be in the 3% to 5% range, which is in line with its multi-year framework. 

In a year with a weak base, however, it does not sound terribly positive to me. Also, one of its key growth markets is India, which is seeing a fresh wave of coronavirus restrictions. 

I like the stock as a long-term buy, but if I had a three-year holding period in mind, I will consider it carefully. 

#2. GlaxoSmithKline: results disappoint

The FTSE 100 pharmaceuticals and healthcare biggie, GlaxoSmithKline, posted a poor set of Q1 2021 results yesterday with an 18% fall in turnover compared to Q1 2020. Net profits fell by 25% and earnings per share are down by 32%. 

The company attributes this washout performance to Covid-19-related disruptions. Considering its strong performance in the years before, I am optimistic for its future. This is further strengthened by the fact that it expects “meaningful improvements…in revenues and margins”.

It also has a strong dividend yield of around 6%. I would consider buying it from the income perspective. 

#3. Reckitt Benckiser: mixed bag

Consumer healthcare biggie Reckitt Benckiser, or Reckitt as it now prefers to be called, posted a mixed bag of a trading update yesterday. Its reported a 1.1% decline in reported revenues because of currency fluctuations. 

Its like-for-like sales, however, were up by 4.1%, driven by a huge 28.5 % increase in its hygiene business. The growth in hygiene came from brands like Lysol, Air Wick, and Finish, with geographies like the US, UK, and India reporting double-digit growth. 

But its two other segments, health and nutrition, shrank in Q1, 2021 driven by Covid-19-related restrictions. Like Unilever, another coronavirus wave in India could impact Reckitt in 2021 too. In any case, it expects like-for-like sales to slow down to 2% for the year. 

I would wait and see how its situation develops before buying Reckitt. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Is now the time to buy BP shares? Here’s what the charts say

The best time to buy shares in a company is when they’re trading at a discount. But the future is…

Read more »

Investing Articles

Here’s how I’d use £50K to aim for a million when the stock market crashes

Seeing a stock market crash as a buying opportunity could prove lucrative for a well-prepared, long-term investor. Christopher Ruane explains…

Read more »

Stack of one pound coins falling over
Investing Articles

It’s up 27% with a P/E of 9! I’m considering the potential of this blossoming penny stock

Despite several years of losses, this UK penny stock has an impressive valuation. I’m looking to see if it could…

Read more »

US Stock

The Nvidia share price falls! Here’s what I think happens next for the S&P 500

Jon Smith reviews the overnight results from Nvidia and explains why this could stall the S&P 500 performance through to…

Read more »

Investing Articles

Down 15% today, is this FTSE 100 share too cheap for me to miss?

JD Sports' share price has tanked after the FTSE 100 share released another profit warning. Is this the opportunity I've…

Read more »

Investing Articles

Up 8% today, is this FTSE 100 growth stock a slam-dunk buy for me?

Halma's share price is soaring thanks to another headline-grabbing trading update. Is the FTSE 100 stock now too good for…

Read more »

Investing Articles

With a P/E ratio of just 10.5 is now a brilliant time to buy a cut-price FTSE 250 tracker?

Harvey Jones says a recent dip in the FTSE 250 leaves the index trading at bargain levels. One stock in…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

To build a passive income flow, I’d follow this Warren Buffett approach

Warren Buffett has set up passive income streams most people can only dream about. Our writer sees some practical lessons…

Read more »